S80455 |
Efaproxiral sodium |
源叶(MedMol) | 98% |
- 提示:详情请下载说明书。
- 产品描述: Efaproxiral Sodium , a synthetic allosteric modifier of hemoglobin, is utilized for brain metastases originating from breast cancer.
- 靶点: Reactive Oxygen Species;ReactiveOxygenSpecies
- 体内研究:
Efaproxiral plus oxygen breathing reduces the radiobiological hypoxic fraction of EMT6 tumors from the value of 24% found in both air-breathing and oxygen-breathing mice to 9% and improves the response of the tumors to radiation. Carboplatin (100 mg/kg) slowes tumor growth in air-breathing mice, producing a growth delay of 3.3 days. Efaproxiral plus oxygen increases the growth delay to 5.7 days; this is 2.4 days (71%) greater than that for carboplatin alone and 2.1 days (57%) greater than that for carboplatin plus oxygen breathing. Efaproxiral plus oxygen breathing, therefore, improves the tumor growth delay obtained with 100 mg/kg carboplatin to or beyond that obtained with the highly toxic dose of 150 mg/kg carboplatin, but does so without increasing the toxicity beyond that seen with 100 mg/kg carboplatin in air-breathing mice. Efaproxiral significantly increases tumor oxygenation by 8.4 to 43.4 mmHg within 5 days in C3H mice with RIF-1 tumors, with maximum increases at 22-31 min after treatment. Efaproxiral plus oxygen plus Radiation produces tumor growth inhibition throughout the treatment duration in C3H mice with RIF-1 tumors, and inhibition is significantly different from radiation plus oxygen from day 3 to day 5.
- 参考文献:
1.Donnelly ET, et al. Exp Biol Med (Maywood), 2006, 231(3), 317-321. 2.Hou H, et al. Radiat Res, 2007, 168(2), 218-225.
- 溶解性: H2O:67 mg/mL (184.4 mM) DMSO:68 mg/mL (187.1 mM) Ethanol:68 mg/mL (187.1 mM)
- 保存条件: 2-8℃
- 配置溶液浓度参考:
1mg 5mg 10mg 1 mM 2.752 ml 13.76 ml 27.519 ml 5 mM 0.55 ml 2.752 ml 5.504 ml 10 mM 0.275 ml 1.376 ml 2.752 ml 50 mM 0.055 ml 0.275 ml 0.55 ml
- 注意:部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。
输入产品批号:
本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:
质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)